Applications published 6 December 2006
Topical formulations for the treatment of skin conditions
Chemaphor 1727530*
Combined pharmaceutical compsn for the inhibition of the decline of cognitive functions
EGIS Gyogyszergyar 1727531*
Chemically stable compsns of 4-hydroxy tamoxifen
Laboratoires Besins International 1727532*
Use of cysteinyl leukotriene-2 receptor antagonists
Merck; Merck Frosst Canada 1727533*
Hydroxymethylbutyrate compsns and uses thereof
Abbott Laboratories 1727534*
Combinations comprising alpha-2-delta ligands
Pfizer 1727535*
Beta-lapachone and s-phase drug combinations for cancer treatment
Arqule 1727536*
Use of beta-lapachone for treating or preventing cancer
Arqule 1727537*
Combination of an NMDA receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other CNS disorders
Neuromolecular 1727538*
Use of rotigotine for treating and preventing parkinson's plus syndrome
Schwarz Pharma 1727539*
Melanin-concentrating hormone receptor antagonists and methods of use
The Regents of the University of California 1727540*
Imidazole-based HMG-CoA reductase inhibitors
Warner-Lambert 1727541*
Compounds, compsns, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
Cytokine Pharmasciences 1727542*
Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders
Biocortech 1727543*
Use of indazolecarboxamide derivatives for the preparation of a medicament that is intended for the treatment and prevention of paludism
Sanofi-Aventis 1727544*
Use of N-piperidine derivatives for the treatment of neurodegenerative pathologies
Medestea Research & Production 1727545*
Methods and formulations for protecting cells, and for treating diseases and conditions by optimising the intracellular concentration of NAD
Robarts Research Institute 1727546*
Compounds for the sustained reduction of body weight
Neurosearch 1727547*
Use of carboxypeptidase G for combating antifolate toxicity
Protherics Medicines Development 1727548*
Intranasal benzodiazepine compsns
University of Kentucky Research Foundation 1727549*
Pharmaceutical compsn comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein
Arrow Therapeutics 1727550*
Pharmaceutical compsn comprising a benzodiazepine derivative and a inhibitor of the RSV fusion protein
Arrow Therapeutics 1727551*
Tissue repair with multipotent cells
Universiteit Twente 1727552*
Agent for substitution of blood plasma and a method of its production
Parenteral 1727553*
Methods of treating psychiatric, substance abuse, and other disorders using combinations containing omega-3 fatty acids
The McLean Hospital Corporation 1727554*
Production of hop extracts having oestrogenic and antiproliferative bioactivity
Biodynamics 1727555*
Materials and methods for treatment of inflammatory and cell proliferation disorders
University of South Florida 1727556*
Uses of galectin-2
Charite-Universitaetsmedizin Berlin 1727557*
Use of DMBT1 for capturing sulphate and phosphate group exposing agents
DKFZ Deutsches Krebsforschungszentrum 1727558*
Use of FGF-21 and a thiazolidinedione for treating type 2 diabetes
Eli Lilly 1727559*
Gastrointestinal proliferative factor and uses thereof
Nuvelo; Kirin Beer Kabushiki Kaisha 1727560*
Lactalbumin for inhibiting angiogenesis
Hamlet Pharma 1727561*
Method of vaccination against testicular BVDV infection
Pharmacia & Upjohn 1727562*
Method for amplifying therapeutic vaccine activity
Biovaxim 1727563*
CD44-targeting for reducing/preventing ischaemia-reperfusion injury
Academisch Ziekenhuis Bij de Universiteit van Amsterdam 1727564*
Lubricant for the ocular surface
Melbj Holdings 1727565*
Conjugated psychotropic drugs and uses thereof
Ramot at Tel Aviv University 1727566*
Aptamer therapeutics useful in the treatment of complement-related disorders
Archemix 1727567*
Method and materials for use in diagnosing viral myocarditis
The Regents of the University of California 1727568*
Compsns of alpha and beta chitosan and methods of preparing them
Medtrade Products 1727569*
Methods for preparing medical implants from calcium phosphate cement and medical implants
Calcitec 1727570*
Method for obtaining graded pore structure in scaffolds for tissues and bone, and scaffolds with graded pore structure for tissue and bone
Agency for Science, Technology and Research; Rapid-Tech 1727571*